If you are an Aetna member and received a letter regarding contract negotiations with NewYork-Presbyterian, you may find out the latest information here.

Ellen K. Ritchie, M.D.

Hematology/Oncology

Locations and Appointments

Insurances Accepted

Please contact the doctor's office to verify that your insurance is accepted.

  • HMO
  • Medicare
  • PPO
  • EPO/POS
  • CHP
  • Blue Access
  • Blue Connection
  • EPO
  • HMO
  • Mediblue (Senior)
  • PPO
  • CBP
  • Medicaid
  • Medicare
  • Freedom
  • Liberty
  • Medicare Advantage
  • Metro/Core/Charter
  • Community Plan
  • Medicare
  • HMO
  • Medicare
Personal Statement

Ellen K. Ritchie, MD is assistant professor of medicine and a member of the Leukemia Program at the Weill Cornell Medical College of Cornell University and the New York Presbyterian Hospital in New York City.

Dr. Ritchie graduated from Barnard College at Columbia University and received her medical degree from the College of Physicians and Surgeons at Columbia University in New York City. She was elected to the Alpha Omega Alpha Honor Society. She completed her internship and residency in internal medicine at New York Presbyterian Hospital, Columbia campus. Dr. Ritchie completed her fellowship in hematology and medical oncology at the New York Presbyterian Hospital, Columbia campus. Dr. Ritchie's research interests are in the treatment of older patients with anemia, cytopenias, myelodysplastic syndromes, myeloproliferative disorders and acute leukemia. She is interested in finding better therapies and supportive care strategies for older patients. Dr. Ritchie is the principal investigator on clinical trials investigating new diagnostic techniques, supportive care strategies and therapeutics aimed at the older patient. She collaborates with investigators in the Division of Geriatrics and Gerontology. She has been the author or co-author of many publications. She is interested in improving the medical care of older patients with hematologic malignancies.

Biographical Info

Dr. Ritchie graduated from Barnard College at Columbia University and received her medical degree from the College of Physicians and Surgeons at Columbia University in New York City. She was elected to the Alpha Omega Alpha Honor Society. She completed her internship and residency in internal medicine at New York Presbyterian Hospital, Columbia campus. Dr. Ritchie completed her fellowship in hematology and medical oncology at the New York Presbyterian Hospital, Columbia campus.

Honors and Awards

Alpha Omega Alpha 10/96

Arnold P. Gold Foundation Award 5/97

Board Certifications
American Board of Internal Medicine
American Board of Internal Medicine (Hematology)
American Board of Internal Medicine (Medical Oncology)
Clinical Expertise
Leukemia
Myeloproliferative Disorder
Myelodysplastic Syndrome
Myeloproliferative Disease
Anemia
Myeloproliferative Neoplasm
MPN (Myeloproliferative Neoplasm)
Chronic Myelogenous Leukemia
Essential Thrombocythemia
ET (Essential Thrombocythemia)
CML (Chronic Myeloid Leukemia)
Polycythemia Vera
Myelofibrosis
MF (Myelofibrosis)
Hypereosinophilic Syndrome
Languages
English
Education 
  • M.D.
    Columbia University College of Physicians and Surgeons
    1997
Appointments 
  • Associate Attending Physician
    NewYork-Presbyterian Hospital
  • Associate Professor of Clinical Medicine
    Weill Cornell Medical College, Cornell University
Videos

Ellen Ritchie, MD

About Us | Richard T. Silver Myeloproliferative Neoplasms (MPN) Center

Acute Myeloid Leukemia | Minerva's Story

Relationships and collaborations with for-profit and not-for profit organizations are of vital importance to our faculty because these exchanges of scientific information foster innovation. As experts in their fields, WCM physicians and scientists are sought after by many organizations to consult and educate. WCM and its faculty make this information available to the public, thus creating a transparent environment.

Consultant: 
Jazz Pharmaceuticals, Inc.
Novartis Pharma AG
Takeda Pharmaceutical Company Limited
Advisory/Scientific Board Member: 
Astellas Pharma Inc.
Speaker/Lecturer: 
Incyte, Inc.